Supporting patients with metabolic disorders accessing further education

Craigavon, U.K. – 27 Jul 2021 - Galen, the privately-owned pharmaceutical sales and marketing company, is pleased to announce the inaugural Galen Medical Nutrition Scholarship Award designed to support people with metabolic disorders, such as Phenylketonuria (PKU), accessing further education, training and development courses or apprenticeships.

Entrants are required to complete an application form and submit a personal statement (1000 words or less) describing their educational plans and how this scholarship will enable them to achieve their personal and career goals. Two scholarships will be awarded to people with metabolic disorders and the award is open to applicants right across Europe.

The prize-winners will each win a bursary of up to £2,000/€2,500 towards their education/training course fees, in addition to a full technology package worth £2,000 including a state-of-the-art laptop, monitor, tablet, Apple watch and AirPods and a £200 voucher for study aids. Due to restrictions imposed as a result of COVID-19, the 2021 awards will be presented to the recipient at ceremonies in September.

The Galen Medical Nutrition Awards committee, which will include representatives from the metabolic disease community, will evaluate entries and select two winners based on their written entry, aspirations and commitment to study.

Dr Dennise Broderick, Managing Director & President, Galen, said: “We recognise that people who are born with metabolic disorders, such as PKU, and receive the correct treatment can absolutely have the same educational and career goals as anyone else. Galen is committed to bringing innovation, quality and customer focus to people diagnosed with this condition and we are delighted to launch this scholarship programme to offer support and encourage the aspirations of individuals who deserve the opportunity to fulfil their ambition. 

She continued: “We look forward to awarding this year’s winners and following how they progress over the course of their studies and beyond.” 

Submissions must be made using the Galen Medical Nutrition Scholarship Award Entry Form – www.galen-pharma.com/galen-medical-nutrition-scholarship and submitted via email to This email address is being protected from spambots. You need JavaScript enabled to view it. by 1700hrs (BST) on Friday 03 September 2021.

#END#

Notes to editors

About Galen

Established in 1968, Galen is a privately owned pharmaceutical sales and marketing company, headquartered in Craigavon (Northern Ireland), with products in therapy areas including gastroenterology, pain management and dermatology.

As a subsidiary of Galen Limited, Galen US also has a growing presence in select conditions such as those requiring topical anaesthesia. The company plans to continue expanding its portfolio with selected speciality products on an international basis. By combining innovation in product development with competitive pricing, Galen aims to work in partnership with healthcare professionals and patients to create real, long-term value.

For further information please visit: www.galen-pharma.com

About Almac Group

Galen is a member of the Almac Group. The Almac Group is an established contract development and manufacturing organisation providing an extensive range of integrated services across, and beyond, the drug development lifecycle to the pharmaceutical and biotech sectors globally.

Almac’s innovative services range from R&D, biomarker discovery development and commercialisation, API manufacture, analytical services, formulation development, clinical trial supply, IRT (IVRS/IWRS) through to commercial-scale manufacture, product development and marketing.

The international company is a privately owned organisation that has grown organically over the past five decades and now employs over 6,000 highly skilled personnel across 18 facilities globally.

For further information please visit www.almacgroup.com.